Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease?

Hickman, Ingrid J., Russell, Anthony W., Prins, Johannes B. and Macdonald, Graeme A. (2008) Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease?. Diabetes Research and Clinical Practice, 80 1: e10-e12. doi:10.1016/j.diabres.2007.11.016


Author Hickman, Ingrid J.
Russell, Anthony W.
Prins, Johannes B.
Macdonald, Graeme A.
Title Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease?
Journal name Diabetes Research and Clinical Practice   Check publisher's open access policy
ISSN 0168-8227
1872-8227
Publication date 2008-04-01
Year available 2008
Sub-type Article (original research)
DOI 10.1016/j.diabres.2007.11.016
Volume 80
Issue 1
Start page e10
End page e12
Total pages 3
Editor N. Hotta
Place of publication Shannon, Ireland
Publisher Elsevier Ireland
Language eng
Subject C1
110306 Endocrinology
920106 Endocrine Organs and Diseases (excl. Diabetes)
1103 Clinical Sciences
Abstract Raised liver enzymes are common in type 2 diabetes (T2DM) but often considered benign. Non-alcoholic fatty liver was the cause in 65% of cases but other causes included alcoholic liver disease and viral hepatitis. Cirrhosis was identified in 11 patients. There is a significant burden of advanced liver diseases from a variety of aetiologies in patients with T2DM. Copyright © 2008 Elsevier Ireland Ltd
Keyword Type 2 diabetes
NAFLD
Cirrhosis
Liver enzymes
Q-Index Code C1
Q-Index Status Confirmed Code

 
Versions
Version Filter Type
Citation counts: Scopus Citation Count Cited 7 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Thu, 26 Mar 2009, 22:22:21 EST by Kylie Hengst on behalf of UQ Diamantina Institute